BD to invest $65 million for medical device supply chain infrastructure to increase resiliency

April 1, 2021

Becton, Dickinson and Company (BD) announced it will invest $65 million to construct a state-of-the-art facility in Tucson, AZ that will be a hub for the company's supply chain, serving as a final-stage manufacturing and sterilization center.   

The new 120,000 square-foot facility will be built on approximately 32 acres at the northeast corner of Valencia and Kolb Road and is planned to be operational in mid-2022. BD plans to add approximately 40 new jobs, including engineers, scientists, quality control specialists and other skilled talent. Sun Corridor, Inc. projects that BD's investment will have a $122 million economic impact over the next 10 years. 

As part of the company's response to COVID-19 and commitment to public health, BD is investing significantly in its in-house capacity for manufacturing and sterilization. This facility will advance BD's goals of improved overall operational efficiency, customer service levels and supply chain resilience. 

This transformational project expands the footprint BD already has in Arizona, which includes a $1 billion BD Peripheral Intervention business unit headquartered in Tempe. BD operates more than 90 medical device and health care technology manufacturing and sterilization facilities globally and has a track record of sustainable operations. This facility will be one of the first in the world with an original design that will meet or exceed the most stringent environmental guidelines and serve as a model for other sites worldwide. 

BD has the release.

More COVID-19 coverage HERE.